Clinical Guidelines
Commentary & Perspectives
Feature

Inside the Race to Detect Neurodegenerative Disease Early

Unlocking a new frontier in diagnosing and understanding complex brain diseases long before symptoms appear

Share

7 Key Takeaways

  • 1

    Early detection of neurodegenerative diseases is vital for patient outcomes.

  • 2

    Amprion focuses on diagnostics for Alzheimer's, Parkinson's, and Huntington’s diseases.

  • 3

    SAAmplify-αSyn assay shows exceptional accuracy in detecting biomarkers.

  • 4

    The test can identify active disease years before clinical diagnosis.

  • 5

    Precision medicine is emerging as a diagnostic approach.

  • 6

    Innovations in AI and biomarker science are shaping future diagnostics.

  • 7

    80 million people worldwide live with neurodegenerative diseases.

Original Source(s)

Inside the Race to Detect Neurodegenerative Disease Early

Unlocking a new frontier in diagnosing and understanding complex brain diseases long before symptoms appear

  • by Jessica Allerton

  • November 27, 2025

  • 6 min

Related Content

FDA OKs First SMA Gene Replacement Therapy

The FDA approved Itvisma, the first gene replacement therapy for children 2 years and older, teens, and adults with spinal muscular atrophy, a one-time treatment that replaces the SMN1 gene and demonstrated improved motor function in Phase 3 studies.

Brain Shifts at Hidden Ages 

Manifold analysis reveals distinct organizational epochs separated by turning points at ages 9, 32, 66, and 83 years across 4,216 diffusion imaging scans.

Brain Stimulation Boosts Vision Recovery

Cross-frequency tACS combined with visual training significantly improved motion discrimination and expanded visual fields in chronic hemianopia patients.